MVGBX
Price
$18.15
Change
+$0.01 (+0.06%)
Updated
Aug 15 closing price
Net Assets
300.92M
RWIBX
Price
$71.57
Change
+$0.05 (+0.07%)
Updated
Aug 15 closing price
Net Assets
137.49B
Interact to see
Advertisement

MVGBX vs RWIBX

Header iconMVGBX vs RWIBX Comparison
Open Charts MVGBX vs RWIBXBanner chart's image
MFS Low Volatility Global Equity B
Price$18.15
Change+$0.01 (+0.06%)
VolumeN/A
Net Assets300.92M
American Funds Capital World Gr&Inc R2
Price$71.57
Change+$0.05 (+0.07%)
VolumeN/A
Net Assets137.49B
MVGBX vs RWIBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MVGBX vs. RWIBX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MVGBX is a StrongBuy and RWIBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 137B vs. MVGBX (301M). MVGBX pays higher dividends than RWIBX: MVGBX (0.88) vs RWIBX (0.82). MVGBX was incepted earlier than RWIBX: MVGBX (12 years) vs RWIBX (23 years). MVGBX (1.82) is less costly to investors than RWIBX (1.51). MVGBX is a more actively managed with annual turnover of: 32.00 vs. RWIBX (27.00). RWIBX has a lower initial minimum investment than MVGBX: RWIBX (250) vs MVGBX (1000). RWIBX annual gain was more profitable for investors over the last year : 10.52 vs. MVGBX (4.79). RWIBX return over 5 years is better than : 43.49 vs. MVGBX (33.40).
MVGBXRWIBXMVGBX / RWIBX
Total Expense Ratio1.761.51117%
Annual Report Gross Expense Ratio1.821.51121%
Fund Existence12 years23 years-
Gain YTD11.29414.94376%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets301M137B0%
Annual Yield % from dividends0.880.82107%
Returns for 1 year4.7910.5246%
Returns for 3 years24.5238.4664%
Returns for 5 years33.4043.4977%
Returns for 10 years69.0659.55116%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OCGN1.050.02
+1.94%
Ocugen
JANX25.110.14
+0.56%
Janux Therapeutics
DMAAU10.60N/A
N/A
Drugs Made In America Acquisition Corp
AXS95.25-2.08
-2.14%
Axis Capital Holders Limited
REFR1.47-0.05
-3.29%
Research Frontiers